65,437 trials
COVID-19
Primary: Modified COVID Ordinal Outcomes Scale: Study Day 15 (Group 2 and Placebo Control Group) — 0; 0; 1; 0 Participants
Head Trauma · Image, Body
Primary: Sensitivity: Percentage of MRIs Correctly Identifying Clinically Important Intracranial Injury (True Positives) — 70 Percentage of MRIs correctly identifying
Primary Open Angle Glaucoma · Ocular Hypertension
Primary: Intraocular Pressure at Week 2 — 19.05; 18.92; 18.28; 17.86 mmHg
Telemedicine
Primary: Hemoglobin A1c — 8.58; 9.19 % HbA1c — p=0.02
Anesthesia
Primary: The Hemoglobin (in g/dl) Levels — 12.2; 12.0; 11.9; 11.8 g/dl
Molluscum Contagiosum
Primary: Complete Clearance of All Treatable MC at Week 12 — 144; 88 Participants
Visual Performance
Primary: Photopic Contrast Sensitivity at 6 Cpd — 1.46; 1.91 Log Unit
Child
Primary: Temperature Difference (in Degrees Celsius) Between 2 Body Sites in Children Undergoing General Anaesthesia. The 2 Sites Are: (1) Lower Oesophagus; (2) Nasopharynx…
Neurogenic Bowel
Primary: Questionnaire Measuring Subjects' Satisfaction of Navina Smart — 1; 14; 13 Participants
Mental Illness · Shared Decision Making
Primary: Patient Activation Measure for Mental Health (PAM-MH) — 59.8; 61.6 units on a scale
Schizophrenia
Primary: Clutter Image Rating Scale (CIRS) - Blind-rated — 2.28 score on a scale
Rheumatoid Arthritis
Primary: Stage 1: Percentage of Participants Who Achieved 20 Percent (%) American College of Rheumatology C-reactive Protein (ACR20-CRP) Response Rate at Week 22 — 56.6; 53.0…
Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) · Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) · Cohort 3a and 3b: Chondrosarcoma
Primary: Number of Participants With a Dose Limiting Toxicity (DLT) — 0; 2; 0; 1 Participants
Arthroplasty, Replacement, Knee
Primary: Stair Climbing Task (SCT) — 14.3; 13.8 seconds
Heart Failure · Sleep Apnea Syndromes
Primary: Left Ventricular Ejection Fraction — 1.63; 1.69; 4.42 percent of LV diastolic volume